Lemsip Max Daytime Cold & Flu Relief

Quick links

Choose a section

Quick links to important sections

Advertisements

Lemsip Max Daytime Cold & Flu Relief

Advertisements
Advertisements
Advertisements

Overview of Lemsip Max Daytime Cold & Flu Relief

Property Description
Active Ingredients Paracetamol, Phenylephrine, Caffeine
Form Powder for oral solution (hot drink)
Pharmacological Class Analgesic, Antipyretic, Decongestant, CNS Stimulant
Common Type Fixed-dose combination (FDC)
Origin Synthetic chemical substances

What Type of Medicine is Lemsip Max Daytime Cold & Flu Relief?

Lemsip Max Daytime Cold & Flu Relief is classified as an Over-the-Counter (OTC), proprietary fixed-dose combination (FDC) drug composed of multiple active pharmaceutical ingredients intended for the simultaneous symptomatic management of cold and flu. This product is an oral preparation, typically administered as a powder for solution to be consumed as a hot drink, which is a common dosage format for targeted cold relief. This formulation is globally recognized as a multi-action medicine, combining an analgesic, an antipyretic, a nasal decongestant, and a mild CNS stimulant.

Composition: A Tripartite Blend of Synthetic Agents

The active therapeutic profile is derived from three distinct synthetic chemical entities: Paracetamol (Acetaminophen), Phenylephrine Hydrochloride, and Caffeine. Paracetamol belongs to the drug class of miscellaneous analgesics and is clinically recognized for its reliable action in reducing pain and fever. Phenylephrine Hydrochloride is a sympathomimetic amine that provides necessary decongestant action by constricting blood vessels. The final component, Caffeine, is added as a mild stimulant to specifically address the fatigue and lethargy often associated with viral illness, differentiating the product as a dedicated Daytime formula.

General Purpose: Multi-Symptom Relief for Cold and Flu

The overall function of this specific combination is to achieve concurrent symptomatic relief by targeting multiple physiological complaints inherent to the common cold and influenza. Combination products are used to simplify the management of overlapping symptoms. The integrated approach provides systemic relief—reducing body aches and controlling fever—and local relief—clearing nasal congestion, helping the patient manage common situations while maintaining functional capacity during the day.

Regulatory References

  1. Symptomatic Treatment of Common Cold - NIH
  2. Sympathomimetic Agents - NIH
  3. Caffeine - NIH
  4. Caffeine for Fatigue - NIH
Advertisements

What side effects are possible with Lemsip Max Daytime Cold & Flu Relief?

Possible side effects and safety information

The official safety profile for this fixed-dose combination, containing Paracetamol, Phenylephrine, and Caffeine, categorizes documented adverse reactions by frequency and the body system affected. Many potential effects are classified as Not Known, meaning the frequency cannot be reliably determined from available data, while Serious skin reactions are officially documented as Very Rare.

Adverse reactions may be organized into System-Organ-Classes (SOCs) including Blood and Lymphatic System Disorders, Nervous System Disorders (e.g., headache, dizziness), Psychiatric Disorders (e.g., insomnia, restlessness), Cardiac Disorders (e.g., palpitations), Vascular Disorders (e.g., hypertension), and Gastrointestinal Disorders (e.g., nausea, vomiting).

Serious adverse reactions documented in regulatory text include the risk of hepatotoxicity (liver damage) associated with the Paracetamol component and the occurrence of high anion gap metabolic acidosis in patients with specific risk factors such as severe renal impairment, sepsis, or chronic alcoholism.

Safety-related constraints specify that the product should not be used in individuals with pre-existing conditions such as severe coronary heart disease, hypertension, or hyperthyroidism. The official label requires the strict avoidance of concurrent use of other Paracetamol-containing products and the avoidance of excessive caffeine intake from dietary sources. Urinary retention is noted as a potential risk, particularly in males. These official safety statements define the regulatory boundaries for the use of this medicine.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

Category Official Regulatory Statement
Documented Overdose Presentations Initial manifestations often include nausea, vomiting, pallor, anorexia, and abdominal pain. Later signs include evidence of liver damage. Cardiovascular and CNS effects documented are hypertension, palpitations, urination difficulties, insomnia, restlessness, and tremors.
Physiological Systems Affected (as stated in label) Hepatic (liver failure, hepatic necrosis), Renal (acute tubular necrosis, acute renal failure), Cardiovascular (hypertension, arrhythmia, cardiac arrest), Central Nervous System (encephalopathy, cerebral oedema, convulsions).
Emergency-response statements Immediate medical advice must be sought in the event of an overdose, even if the patient feels well, due to the risk of delayed, serious liver damage. Immediate hospitalisation is required for plasma concentration assessment.
Antidote and Supportive Measures The antidote N-acetylcysteine (NAC) is used for Paracetamol toxicity. No specific antidote is known for Phenylephrine, and treatment is primarily symptomatic and supportive.

Population-specific overdose notes: The hazard of liver damage is greater in individuals with non-cirrhotic alcoholic liver disease, chronic alcohol abuse, and in patients who are glutathione deplete.

Connection to the overall overdose profile: Regulatory documents define the overdose profile primarily by the critical, time-dependent hazard of severe hepatic toxicity resulting from the Paracetamol component, which mandates the immediate seeking of medical help regardless of the presence of initial symptoms. The profile also includes acute, symptomatic effects such as cardiovascular and CNS over-stimulation from Phenylephrine and Caffeine. Official instructions center on urgent procedural steps, including hospitalization, plasma concentration measurement, and timely administration of the specific antidote, N-acetylcysteine.

Advertisements

Therapeutic Uses of Lemsip Max Daytime Cold & Flu Relief

What Lemsip Max Daytime Cold & Flu Relief Treats: Main Uses and Benefits

This fixed-dose combination product is relevant in contexts marked by increased discomfort and is primarily used for the symptomatic management of the common cold and influenza. It is applied across domains where additional symptomatic support is needed. It helps address symptom clusters that may become intense or disruptive, including headache, feverishness, sore throat pain, nasal congestion, and general body aches.

The medication is generally used during phases when symptoms become more noticeable and may assist in easing the overall symptom load. It is relevant in situations where temporary assistance in symptom stabilization is important. It is used to help manage the discomfort associated with sinus pressure and fullness and is relevant for easing illness-related fatigue. This supports the patient during difficult episodes by easing distress and assists with maintaining functional stability during the day.


Quick Fact: Relevant for Managing Multiple Symptoms


Regulatory References

  1. HPRA Summary of Product Characteristics
Advertisements

Eligibility and Restrictions for Use

Official Regulatory Eligibility Profile

The eligibility for Lemsip Max Daytime Cold & Flu Relief is strictly defined by regulatory contraindications and age restrictions, primarily due to the presence of Phenylephrine (a sympathomimetic) and Caffeine.

Category Official Regulatory Status
Populations Allowed Adults and adolescents aged mathbfge 16 years.
Age Restriction Contraindicated in children under 16 years of age.
Pregnancy/Lactation Not Recommended during pregnancy or breastfeeding.

Contraindicated Populations (Must Not Use)

The medicine is contraindicated and must not be used by patients with several pre-existing conditions as specified in official labeling:

  • Cardiovascular: Severe coronary heart disease or high blood pressure (hypertension).
  • Metabolic/Glandular: Diabetes mellitus or an overactive thyroid (hyperthyroidism).
  • Neurological/Other: Phaeochromocytoma, closed-angle glaucoma, or known hypersensitivity to any ingredient.
  • Concurrent Medication: Patients currently taking or having taken Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days, or those using other sympathomimetic decongestants.

Conditional Use (Caution Required)

Use requires caution in patients with renal impairment, hepatic impairment, a history of stomach ulcer, prostatic enlargement, or Raynaud's syndrome. For frail elderly subjects, a reduction in dose frequency may be appropriate as stated in the label.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction patterns for Lemsip Max Daytime Cold & Flu Relief, based strictly on government regulatory labeling. The profile is structured around contraindicated combinations, pharmacodynamic modifications, and changes to drug exposure.

  • Formal Prohibitions and Timing Rules: The co-administration of this product with Monoamine Oxidase Inhibitors (MAOIs) is strictly prohibited, including if MAOI therapy was used within the previous 14 days. It is also prohibited to take this medicine with any other paracetamol-containing products or other sympathomimetic decongestants.

  • Interactions Affecting Efficacy and Toxicity:

    • Phenylephrine may reduce the efficacy of medicines for high blood pressure, such as Beta-Blockers. The combination with Cardiac Glycosides or Tricyclic Antidepressants may increase the risk of cardiovascular side effects.
    • Prolonged regular daily use of the Paracetamol component may enhance the effect of oral anticoagulants (e.g., Warfarin), increasing the documented bleeding risk.
    • The speed of Paracetamol absorption is increased by Metoclopramide and reduced by Cholestyramine. Substances that induce liver microsomal enzymes (e.g., Carbamazepine, Isoniazid) may increase the hepatotoxic potential of Paracetamol.
    • Caffeine clearance is documented to be inhibited by Oral Contraceptive Steroids and Cimetidine.
  • Substance and Population Factors: Users are advised not to consume large quantities of alcohol due to an increased risk of Paracetamol-related liver damage. The hazard of Paracetamol overdose is officially stated to be greater in patients with non-cirrhotic alcoholic liver disease.

Advertisements

Mechanism of Action

The mechanism of action for Lemsip Max Daytime Cold & Flu Relief involves the distinct pharmacodynamic profiles of its three active components. Paracetamol, crossing the blood-brain barrier, primarily exerts its effects within the central nervous system. Its core molecular action is the inhibition of prostaglandin synthesis, likely via modulation of central cyclooxygenase (COX) enzyme activity, which decreases the concentration of inflammatory mediators, such as prostaglandin E2 (PGE2), in the hypothalamus. This intracellular cascade leads to a system-level re-setting of the thermoregulatory set-point and a modification of nociceptive signaling.

Phenylephrine, a direct-acting sympathomimetic amine, functions as an agonist at peripheral alpha1-adrenergic receptors. Its binding to these receptors on vascular smooth muscle cells initiates a Gq protein cascade, increasing intracellular calcium concentrations ( Ca^2+) via phospholipase C and inositol trisphosphate ( IP3) signaling. The resulting smooth muscle contraction induces localized vasoconstriction, predominantly affecting the arterioles of the nasal mucosa.

Caffeine is a central nervous system stimulant that acts as an antagonist at central adenosine receptors, and also non-selectively inhibits phosphodiesterase. This dual action modulates neuronal activity and downstream signaling pathways.

Advertisements

Dosage and Administration Information

How to Use Lemsip Max Daytime Cold & Flu Relief

The usage of Lemsip Max Daytime Cold & Flu Relief is governed by instructions detailing the proper method, frequency, and maximum limits for administration. This product is prepared for oral administration and is intended strictly for short-term symptomatic use.


Official Administration Guidelines

Usage Parameter Instruction
Route of Administration Oral solution, following dissolution.
Standard Single Dose The contents of one sachet (1000 mg Paracetamol).
Dosing Interval A minimum of 4 to 6 hours must elapse between doses.
Maximum Daily Limit No more than 4 sachets (4000 mg Paracetamol) in any 24-hour period.
Preparation Requirement Powder contents must be fully dissolved by stirring in hot water.
Treatment Duration Use is limited to a maximum of 5 consecutive days.
Age Restriction Indicated for use in adults and adolescents aged 16 years and over.

Procedural Framework

Standard guidelines establish that the powder must be dissolved completely in hot water before consumption, defining the required preparation step for the oral route. Administration is structured on an as-needed basis (pro re nata) with a mandatory minimum time interval between each dose to regulate systemic exposure.

The medicine is used according to the principle of administering the minimum effective dose for the shortest time required for symptomatic control. Dosing for the elderly, especially those with impairment, may require a reduction in frequency or amount as deemed appropriate, though the standard adult dose is often applicable.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Lemsip Max Daytime Cold & Flu Relief


Research on the Fixed-Dose Combination for Cold and Flu Symptoms

Research related to this fixed-dose combination (Paracetamol, Phenylephrine, and Caffeine) primarily consists of short-term Randomized Controlled Trials (RCTs). These studies were designed to explore changes in the total severity of common cold and flu symptoms in adult populations. Research examined patient-reported outcomes describing perceived discomfort, including measures related to headache, body aches, feverishness, and nasal congestion.

Studies monitored patients who were experiencing acute or disruptive episodes and provided data show patterns related to how symptoms evolved in the observed populations over defined time intervals. Findings describe patterns observed in the short-term trials that were generally consistent across various studies regarding the existence of reported outcomes. In these research scenarios, the combination was studied for its impact on outcomes reflecting daily functioning or activity level during the period of illness.


Component-Specific Research and Regulatory Review

The combination's three active ingredients have each was studied for their specific roles. Paracetamol (the ingredient studied for analgesic and antipyretic effects) and Caffeine (the ingredient studied for its effect on wakefulness and fatigue) have been evaluated for their individual effects. However, the oral decongestant ingredient, Phenylephrine, has been subject to specific scientific evaluation regarding its bioavailability (absorption).

Dedicated regulatory analyses have described patterns related to the ingredient's limited bioavailability due to its inactivation during its passage through the body. Evidence suggests that, when studied at the doses evaluated, the oral decongestant component was associated with limited, if any, measurable change on nasal passages. Uncertainty remains regarding the full intended action of this decongestant.


Research Gaps and Unstudied Populations

The typical follow-up durations for clinical trials involving this fixed-dose combination reflected the short-term, acute nature of the common cold. Consequently, there is limited information for long-term outcomes or effects of continuous use beyond the acute illness phase. Research so far indicates that the results apply most directly to the populations studied—primarily healthy adults—and comparative evidence is lacking or inconsistent for more vulnerable groups, such as older adults with specific health conditions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Lemsip Max Daytime Cold & Flu Relief (FAQ)

Q: Why do official sources include phenylephrine in oral cold and flu medicines?

A: Official documents state that phenylephrine is included because it is historically recognized as an oral nasal decongestant within regulatory guidelines. However, recent scientific reviews in some regions have indicated that the available evidence does not consistently support its effectiveness at the recommended oral dose.

Q: What types of serious allergic reactions are officially reported for this combination of ingredients?

A: According to the official product information, serious allergic reactions reported include a skin rash and itching, which may sometimes involve swelling of the mouth or face, or difficulty breathing. Very rare cases of serious skin reactions have also been documented.

Q: What is the official reason for not recommending preparation of the sachet version with cold water?

A: The official preparation instructions specify the use of hot water for stirring and dissolving the powder contents. This method is required to achieve the intended dissolution of the medicine for oral administration.

Q: What are the symptoms a user should watch for that might indicate a severe liver problem?

A: Signs noted in official documentation that may be linked to a liver problem include nausea, vomiting, loss of appetite, abdominal discomfort, and yellowing of the skin and eyes. These are warnings related to the paracetamol component documented in official information.

Q: Are there any restrictions on taking this medicine with fluids or food?

A: Official regulatory documents caution users against consuming alcohol while taking this medicine due to the increased risk of liver damage linked to the paracetamol component. Beyond this specific warning, regulatory documents do not detail restrictions on non-alcoholic food or fluids.

Q: Is the inclusion of caffeine intended to speed up the action of paracetamol?

A: Caffeine is included as a central nervous system stimulant in the formulation. In combination products, official information indicates that caffeine is understood to enhance the effectiveness of paracetamol by improving how it is absorbed and distributed in the body.

Q: What is the generally understood difference between the Daytime and Nighttime Lemsip Max formulas?

A: The Daytime formula is specifically differentiated by the inclusion of caffeine, a mild stimulant intended to help counteract the fatigue and lethargy often experienced during a cold or flu. Nighttime formulas typically remove this stimulant and often include a sedating ingredient designed to aid sleep.

Q: What is the typical onset time for the decongestant effects after taking the medicine?

A: Official dosing requirements establish a maximum recommended time interval of 4 to 6 hours between doses. This interval reflects the typical expected duration of therapeutic effect for the decongestant component.

Q: How long should the pain relief effects of a single dose generally last?

A: The maximum duration of the pain relief effects is generally indicated by the official dosing requirements. These guidelines establish that a minimum of 4 hours must pass between each dose, which corresponds to the expected length of action for the analgesic component.

Q: Are there known side effects that could affect a person's ability to drive or operate machinery?

A: The official safety profile notes that the medicine can cause certain side effects, such as dizziness or nervousness, primarily due to the caffeine content. These documented effects carry a potential for impairing a person's ability to drive or operate heavy machinery.

Q: Is it safe to take Lemsip Max Daytime capsules with an ibuprofen tablet?

A: Regulatory information indicates that the paracetamol component of this medicine does not have a documented interaction with non-paracetamol containing painkillers such as ibuprofen. The prohibition on co-use applies specifically to other medicines containing paracetamol.

Q: What are the active components that specifically target a sore throat in the ingredients list?

A: The medicine is officially indicated for the relief of a sore throat. This symptom is targeted specifically through the action of the Paracetamol component, which acts as a painkiller (analgesic).

Q: Can this medicine be used alongside medications for acid reflux?

A: Regulatory documents indicate that the medicine is known to interact with certain medications that affect stomach processes. For example, cimetidine (used for acid reflux) can inhibit the clearance of caffeine, and metoclopramide can increase the speed of paracetamol absorption.

Q: What is the significance of the warning to seek medical advice even if one feels well after an overdose?

A: The warning is issued because symptoms of severe liver problems may be absent or minimal in the first 24 hours following an overdose. This delay occurs because serious liver damage, which can become apparent 12 to 48 hours later, may be progressing while the patient remains asymptomatic.

Q: What are the general cautions for individuals taking medications for high cholesterol while using this product?

A: Regulatory documents detail an interaction with cholestyramine, a medication sometimes used to lower blood cholesterol. This interaction is noted because cholestyramine can reduce the speed at which the paracetamol component is absorbed by the body.

Advertisements

How should Lemsip Max Daytime Cold & Flu Relief be stored and disposed of?

Storage and Disposal Instructions

Storage of Lemsip Max Daytime Cold & Flu Relief is governed by specific regulatory requirements to ensure product stability. The medicine must not be stored above 25 C (77 F) and must be kept in a dry place. The product must remain in its original package, and it should never be used past the expiration date printed on the pack.

Child-Safety Storage

All medicines, including this product, must be stored out of the sight and reach of children to prevent accidental ingestion.

Disposal of Unused Product

Regulatory instructions prohibit discarding the medicine via household waste or wastewater, as these methods may harm the environment. Any unused or expired product must be disposed of properly by consulting a pharmacist for guidance on medicinal waste procedures.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lemsip Max Daytime Cold & Flu Relief found in:

A-Z Index: